Giacomo Pavesi

Giacomo Pavesi

Auto-generated profile, based on publicly available information

Giacomo Pavesi

Department of Neurosciences, Neurosurgery Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
GGGiulia Golinelli
Giulia Golinelli
GGGiulia Grisendi
Giulia Grisendi
MPMalvina Prapa
Malvina Prapa
MBMarco Bestagno
Marco Bestagno
CSCarlotta Spano
Carlotta Spano
MDMassimo Dominici
Massimo Dominici
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer molecules represents a promising cell-based strategy. We previously showed that the pro-apoptotic agent tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can be successfully delivered by MSCs to cancer sites. While the interaction between TRAIL and its receptors is clear, more obscure is the way in which MSCs can selectively target tumors and their antigens. Several neuroectoderm-derived neoplasms, including glioblastoma (GBM), sarcomas, and neuroblastoma, express high levels of the tumor-associated antigen GD2. We have already challenged this cell surface disialoganglioside by a chimeric antigen receptor (CAR)-T cell approach against neuroblastoma. With the intent to maximize the therapeutic profile of MSCs delivering TRAIL, we here originally developed a bi-functional strategy where TRAIL is delivered by MSCs that are also gene modified with the truncated form of the anti-GD2 CAR (GD2 tCAR) to mediate an immunoselective recognition of GD2-positive tumors. These bi-functional MSCs expressed high levels of TRAIL and GD2 tCAR associated with a robust anti-tumor activity against GD2-positive GBM cells. Most importantly, the anti-cancer action was reinforced by the enhanced targeting potential of such bi-functional cells. Collectively, our results suggest that a truncated anti-GD2 CAR might be a powerful new tool to redirect MSCs carrying TRAIL against GD2-expressing tumors. This affinity-based dual targeting holds the promise to combine site-specific and prolonged retention of MSCs in GD2-expressing tumors, thereby providing a more effective delivery of TRAIL for still incurable cancers.

1 January 2017 in Journal of Neurosurgery
Verified
Journal Article
Closed access
DMDaniele Marchioni
Daniele Marchioni
Matteo Alicandri-CiufelliMatteo Alicandri-Ciufelli
Matteo Alicandri-Ciufelli
ARAlessia Rubini
Alessia Rubini
BMBabara Masotto
Babara Masotto
GPGiacomo Pavesi
Giacomo Pavesi
LPLivio Presutti
Livio Presutti
OBJECTIVE: The aim of this study was to describe the first case series in which an exclusive endoscopic transcanal transpromontorial approach (EETTA) was used to treat small vestibular schwannomas (VSs) and meningiomas of the internal auditory canal (IAC). METHODS: The authors performed a retrospective review of patients who had undergone surgery using an EETTA to the IAC at 2 university tertiary care referral centers during the period from November 2011 to January 2015. RESULTS: Ten patients underwent surgery via an EETTA for the treatment of VS in the IAC at the University Hospital of Modena or the University Hospital of Verona. The patients had Koos Grade I or II tumors and American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) Class D hearing status preoperatively. Gross-total resection was achieved in all patients. No major complications such as cerebrospinal fluid leakage or hemorrhage were reported. In 7 of 10 (70%) patients, facial nerve function was normal immediately after surgery (Rough Grading System [RGS] Grade I). Two patients presented with a transitory facial palsy immediately after surgery (RGS Grade II–III) but experienced complete recovery during the follow-up period. The mean follow-up was 10 months. CONCLUSIONS: The EETTA proved to be successful for the removal of VS or meningioma involving the cochlea, fundus, and IAC, with possible lower complication rates and less invasive procedures than those for traditional microscopic approaches. The potential for the extensive and routine use of this approach in lateral and posterior skull base surgery will depend on the development of technology and surgical refinements and on the diffusion of skull base endoscopic skills among the otolaryngological and neurosurgical communities.

1 May 2011 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
RMRenzo Manara
Renzo Manara
PMPietro Maffei
Pietro Maffei
VCValentina Citton
Valentina Citton
SRSilvia Rizzati
Silvia Rizzati
GBGiulia Bommarito
Giulia Bommarito
CMChiara Martini
Chiara Martini
The concurrence of intracranial aneurysms and acromegaly has been reported and debated previously. Our study in a large number of patients aimed to verify whether acromegaly patients carry a higher risk of harboring intracranial saccular aneurysms and to evaluate the possible relationship using clinical, laboratory, and imaging techniques. A total of 152 of 161 consecutive acromegaly patients (median age, 55.7 yr; 82 females) underwent neuroimaging evaluation of the circle of Willis. Clinical data (disease duration and disease control, hypertension, smoking history, diabetes and dyslipidemia, previous surgery or radiotherapy, previous or current pharmacological therapy), laboratory findings (GH and IGF-I at onset and shortly before examination), and pituitary adenoma imaging features (size and invasiveness of the cavernous sinus) were recorded. Twenty-six patients (17.3%) harbored 40 newly diagnosed intracranial aneurysms; two other patients had previously undergone aneurysm clipping due to subarachnoid hemorrhage. Ten patients had multiple aneurysms; most of the aneurysms were located in the intracranial tract of the internal carotid artery (67.5%); no aneurysms belonged to the vertebrobasilar circulation. The presence of intracranial aneurysms correlated with GH serum values at disease onset (P < 0.05) and showed a trend to a positive correlation with poor disease control (P = 0.06); no other laboratory, clinical, and radiological findings correlated with the presence of intracranial aneurysms. GH serum excess seems to carry an increased risk of developing intracranial aneurysms. A neuroradiological evaluation of the intracranial circulation might therefore be considered in the diagnostic work-up of patients affected with acromegaly.

12 January 2016 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
AFAlberto Feletti
Alberto Feletti
MAMariagiulia Anglani
Mariagiulia Anglani
BSBruno Scarpa
Bruno Scarpa
Francesca SchiaviFrancesca Schiavi
Francesca Schiavi
FBFrancesca Boaretto
Francesca Boaretto
GOGiuseppe Opocher
Giuseppe Opocher
Although many studies have been published about specific lesions characterizing von Hippel-Lindau(VHL) disease, none have dealt with the natural history of the whole disease and the consequent disabilities. We aim to define the comprehensive natural history of VHL disease and to describe the functional disabilities and their impact upon patients' quality of life, thereby tailoring the follow-up schedule accordingly. We performed a prospective analysis on 128 VHL-affected patients beginning in 1996. For each affected organ, we defined intervals between the first and subsequent VHL-related manifestations and compared them with current VHL surveillance protocols. We looked for any association of the number of involved organs with age, sex, type of VHL gene mutation, and functional domain mutation. Ultimately, we assessed the organ-specific disabilities caused by VHL disease. Hemangioblastomas show different patterns of progression depending on their location, whereas both renal cysts and carcinomas have similar progression rates. Surgery for pheochromocytoma and CNS hemangioblastoma is performed earlier than for pancreatic or renal cancer. The number of involved organs is associated with age but not with sex, type of VHL gene mutation, or functional domain mutation. A thorough analysis of functional disabilities showed that age is related to the first-appearing functional impairment, but it is not predictive of the final number of disabilities. Our study defines the disease progression and provides a comprehensive view of the syndrome over time. We analyzed for the first time the functional disability of VHL patients, assessing the progression for each function.

1 April 2018 in World Neurosurgery
Verified
Journal Article
Closed access
Enrico FranceschiEnrico Franceschi
Enrico Franceschi
ATAlicia Tosoni
Alicia Tosoni
SMSantino Minichillo
Santino Minichillo
RDRoberta Depenni
Roberta Depenni
APAlexandro Paccapelo
Alexandro Paccapelo
CNC. Nobile
C. Nobile

8 March 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
LPLivio Presutti
Livio Presutti
Matteo Alicandri-CiufelliMatteo Alicandri-Ciufelli
Matteo Alicandri-Ciufelli
MBMarco Bonali
Marco Bonali
ARAlessia Rubini
Alessia Rubini
GPGiacomo Pavesi
Giacomo Pavesi
DMDaniele Marchioni
Daniele Marchioni